Information about the Entrepreneur
Lin Tsong-Chin, the Chairman of General Biologicals Corporation (GBC), has more than 30 years of experience in the biotechnology industry. He leads the GBC team in the in-vitro diagnostics (IVDs) field, focusing on hepatitis, tumor markers, retrovirus, fertility, thyroid, and steroids.
Chairman Lin has devoted himself to biotechnology since 1989. Continuous innovation is the driving force for the sustainable development of GBC. The core values of GBC are honesty, cooperation, intelligence, and innovation, which will ensure that GBC becomes a comprehensive IVD and protein drug manufacturer in the future and play an important role in the personalized and preventive medicine industry.
Chairman Lin has successfully transformed his career from the IT industry to the biotechnology industry. This career transition presented his life with a new beginning. He believes not being discouraged by prejudice is a key factor to his success in adjusting to new challenges.
There are considerable differences in the IT and biotechnology industries, including the product life cycle and the degree of integration of knowledge. Focus on the initial IT experience and background, would make this transition difficult. However, by ignoring prejudice through innovation, persistence, and determination, the biotechnology industry led by Chairman Lin will continue to flourish.
Lin Tsong-Chin, the Chairman of General Biologicals Corporation (GBC), has more than 30 years of experience in the biotechnology industry. He leads the GBC team in the in-vitro diagnostics (IVDs) field, focusing on hepatitis, tumor markers, retrovirus, fertility, thyroid, and steroids.
Chairman Lin has devoted himself to biotechnology since 1989. Continuous innovation is the driving force for the sustainable development of GBC. The core values of GBC are honesty, cooperation, intelligence, and innovation, which will ensure that GBC becomes a comprehensive IVD and protein drug manufacturer in the future and play an important role in the personalized and preventive medicine industry.
Chairman Lin has successfully transformed his career from the IT industry to the biotechnology industry. This career transition presented his life with a new beginning. He believes not being discouraged by prejudice is a key factor to his success in adjusting to new challenges.
There are considerable differences in the IT and biotechnology industries, including the product life cycle and the degree of integration of knowledge. Focus on the initial IT experience and background, would make this transition difficult. However, by ignoring prejudice through innovation, persistence, and determination, the biotechnology industry led by Chairman Lin will continue to flourish.
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider.
Company Achievements & Role as Entrepreneur
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider. GBC specializes in in-vitro diagnostic instruments and tests, pharmaceutical and consumer products as well as clinical testing services for consumers.
For more than 30 years, its purpose has always been the same: focusing its attention on making diagnostic technology better, more affordable, and more precise for all people. GBC’s diagnostic tests and equipment are trusted by hospital professionals, lab technicians, blood banks, and consumers.
Under Chairman Lin’s leadership, GBC is focused on developing and manufacturing in-vitro diagnostics (IVD) for immunoassay and molecular applications. The company is helping doctors to make important treatment decisions and test for potential diseases.
GBC’s latest developments are COVID-19 Real-Time PCR kits and COVID-19 Antigen Rapid Tests. GBC is committed to benefiting more patients through digital medical diagnosis services. Chairman Lin’s vision is to lead GBC to become a world-class manufacturer and provider of diagnostics and healthcare. Its mission is to help build a better life for people by implementing superior and innovative diagnostic technology and improving everyone’s quality of life anywhere, at any time.
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider. GBC specializes in in-vitro diagnostic instruments and tests, pharmaceutical and consumer products as well as clinical testing services for consumers.
For more than 30 years, its purpose has always been the same: focusing its attention on making diagnostic technology better, more affordable, and more precise for all people. GBC’s diagnostic tests and equipment are trusted by hospital professionals, lab technicians, blood banks, and consumers.
Under Chairman Lin’s leadership, GBC is focused on developing and manufacturing in-vitro diagnostics (IVD) for immunoassay and molecular applications. The company is helping doctors to make important treatment decisions and test for potential diseases.
GBC’s latest developments are COVID-19 Real-Time PCR kits and COVID-19 Antigen Rapid Tests. GBC is committed to benefiting more patients through digital medical diagnosis services. Chairman Lin’s vision is to lead GBC to become a world-class manufacturer and provider of diagnostics and healthcare. Its mission is to help build a better life for people by implementing superior and innovative diagnostic technology and improving everyone’s quality of life anywhere, at any time.
MASTER ENTREPRENEUR CATEGORY
LIN TSONG-CHIN
CHAIRMAN
Information about the Entrepreneur
Lin Tsong-Chin, the Chairman of General Biologicals Corporation (GBC), has more than 30 years of experience in the biotechnology industry. He leads the GBC team in the in-vitro diagnostics (IVDs) field, focusing on hepatitis, tumor markers, retrovirus, fertility, thyroid, and steroids.
Chairman Lin has devoted himself to biotechnology since 1989. Continuous innovation is the driving force for the sustainable development of GBC. The core values of GBC are honesty, cooperation, intelligence, and innovation, which will ensure that GBC becomes a comprehensive IVD and protein drug manufacturer in the future and play an important role in the personalized and preventive medicine industry.
Chairman Lin has successfully transformed his career from the IT industry to the biotechnology industry. This career transition presented his life with a new beginning. He believes not being discouraged by prejudice is a key factor to his success in adjusting to new challenges.
There are considerable differences in the IT and biotechnology industries, including the product life cycle and the degree of integration of knowledge. Focus on the initial IT experience and background, would make this transition difficult. However, by ignoring prejudice through innovation, persistence, and determination, the biotechnology industry led by Chairman Lin will continue to flourish.
Lin Tsong-Chin, the Chairman of General Biologicals Corporation (GBC), has more than 30 years of experience in the biotechnology industry. He leads the GBC team in the in-vitro diagnostics (IVDs) field, focusing on hepatitis, tumor markers, retrovirus, fertility, thyroid, and steroids.
Chairman Lin has devoted himself to biotechnology since 1989. Continuous innovation is the driving force for the sustainable development of GBC. The core values of GBC are honesty, cooperation, intelligence, and innovation, which will ensure that GBC becomes a comprehensive IVD and protein drug manufacturer in the future and play an important role in the personalized and preventive medicine industry.
Chairman Lin has successfully transformed his career from the IT industry to the biotechnology industry. This career transition presented his life with a new beginning. He believes not being discouraged by prejudice is a key factor to his success in adjusting to new challenges.
There are considerable differences in the IT and biotechnology industries, including the product life cycle and the degree of integration of knowledge. Focus on the initial IT experience and background, would make this transition difficult. However, by ignoring prejudice through innovation, persistence, and determination, the biotechnology industry led by Chairman Lin will continue to flourish.
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider.
Company Achievements & Role as Entrepreneur
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider. GBC specializes in in-vitro diagnostic instruments and tests, pharmaceutical and consumer products as well as clinical testing services for consumers.
For more than 30 years, its purpose has always been the same: focusing its attention on making diagnostic technology better, more affordable, and more precise for all people. GBC’s diagnostic tests and equipment are trusted by hospital professionals, lab technicians, blood banks, and consumers.
Under Chairman Lin’s leadership, GBC is focused on developing and manufacturing in-vitro diagnostics (IVD) for immunoassay and molecular applications. The company is helping doctors to make important treatment decisions and test for potential diseases.
GBC’s latest developments are COVID-19 Real-Time PCR kits and COVID-19 Antigen Rapid Tests. GBC is committed to benefiting more patients through digital medical diagnosis services. Chairman Lin’s vision is to lead GBC to become a world-class manufacturer and provider of diagnostics and healthcare. Its mission is to help build a better life for people by implementing superior and innovative diagnostic technology and improving everyone’s quality of life anywhere, at any time.
Chairman Lin has led GBC to become a leading world-class manufacturing IVD and healthcare, service provider. GBC specializes in in-vitro diagnostic instruments and tests, pharmaceutical and consumer products as well as clinical testing services for consumers.
For more than 30 years, its purpose has always been the same: focusing its attention on making diagnostic technology better, more affordable, and more precise for all people. GBC’s diagnostic tests and equipment are trusted by hospital professionals, lab technicians, blood banks, and consumers.
Under Chairman Lin’s leadership, GBC is focused on developing and manufacturing in-vitro diagnostics (IVD) for immunoassay and molecular applications. The company is helping doctors to make important treatment decisions and test for potential diseases.
GBC’s latest developments are COVID-19 Real-Time PCR kits and COVID-19 Antigen Rapid Tests. GBC is committed to benefiting more patients through digital medical diagnosis services. Chairman Lin’s vision is to lead GBC to become a world-class manufacturer and provider of diagnostics and healthcare. Its mission is to help build a better life for people by implementing superior and innovative diagnostic technology and improving everyone’s quality of life anywhere, at any time.